tradingkey.logo

Omnicell Inc

OMCL
35.404USD
-0.156-0.44%
Horarios del mercado ETCotizaciones retrasadas 15 min
1.59BCap. mercado
79.76P/E TTM

Más Datos de Omnicell Inc Compañía

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Información de Omnicell Inc

Símbolo de cotizaciónOMCL
Nombre de la empresaOmnicell Inc
Fecha de salida a bolsaAug 08, 2001
Director ejecutivoMr. Randall A. Lipps
Número de empleados3670
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 08
Dirección4220 North Freeway
CiudadFORT WORTH
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal76137
Teléfono18774159990
Sitio Webhttps://www.omnicell.com/
Símbolo de cotizaciónOMCL
Fecha de salida a bolsaAug 08, 2001
Director ejecutivoMr. Randall A. Lipps

Ejecutivos de Omnicell Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Randall A. Lipps
Mr. Randall A. Lipps
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
428.14K
-1.93%
Mr. Nnamdi Njoku
Mr. Nnamdi Njoku
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
90.93K
+69.90%
Mr. Robin Gene Seim
Mr. Robin Gene Seim
Independent Director
Independent Director
47.35K
+16.85%
Ms. Joanne B. Bauer
Ms. Joanne B. Bauer
Lead Independent Director
Lead Independent Director
44.90K
+18.74%
Mr. Bruce E. Scott
Mr. Bruce E. Scott
Independent Director
Independent Director
22.97K
+42.59%
Mr. Edward Peter Bousa
Mr. Edward Peter Bousa
Independent Director
Independent Director
17.99K
+56.40%
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
17.18K
+70.20%
Mr. Corey J. Manley
Mr. Corey J. Manley
Executive Vice President, Chief Legal and Administrative Officer
Executive Vice President, Chief Legal and Administrative Officer
14.60K
-21.00%
Mr. Kaushik (Bobby) Ghoshal
Mr. Kaushik (Bobby) Ghoshal
Independent Director
Independent Director
14.52K
+78.84%
Mr. Baird Radford
Mr. Baird Radford
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Randall A. Lipps
Mr. Randall A. Lipps
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
428.14K
-1.93%
Mr. Nnamdi Njoku
Mr. Nnamdi Njoku
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
90.93K
+69.90%
Mr. Robin Gene Seim
Mr. Robin Gene Seim
Independent Director
Independent Director
47.35K
+16.85%
Ms. Joanne B. Bauer
Ms. Joanne B. Bauer
Lead Independent Director
Lead Independent Director
44.90K
+18.74%
Mr. Bruce E. Scott
Mr. Bruce E. Scott
Independent Director
Independent Director
22.97K
+42.59%
Mr. Edward Peter Bousa
Mr. Edward Peter Bousa
Independent Director
Independent Director
17.99K
+56.40%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Connected devices, software licenses, and other
138.62M
47.71%
Technical services
63.77M
21.95%
SaaS and Expert Services
63.62M
21.90%
Consumables
24.55M
8.45%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
263.45M
90.67%
Rest of the World
27.12M
9.33%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Connected devices, software licenses, and other
138.62M
47.71%
Technical services
63.77M
21.95%
SaaS and Expert Services
63.62M
21.90%
Consumables
24.55M
8.45%

Estadísticas de accionistas

Actualizado: jue., 13 de nov
Actualizado: jue., 13 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.92%
The Vanguard Group, Inc.
12.46%
Dimensional Fund Advisors, L.P.
5.27%
State Street Investment Management (US)
4.66%
Lazard Asset Management, L.L.C.
3.81%
Otro
58.88%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.92%
The Vanguard Group, Inc.
12.46%
Dimensional Fund Advisors, L.P.
5.27%
State Street Investment Management (US)
4.66%
Lazard Asset Management, L.L.C.
3.81%
Otro
58.88%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
48.79%
Investment Advisor/Hedge Fund
34.81%
Hedge Fund
14.22%
Research Firm
2.98%
Individual Investor
1.91%
Pension Fund
1.35%
Bank and Trust
0.99%
Sovereign Wealth Fund
0.37%
Family Office
0.05%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
643
48.76M
108.63%
-7.60M
2025Q2
681
49.10M
106.89%
-9.34M
2025Q1
708
50.20M
107.17%
-8.54M
2024Q4
716
48.64M
104.03%
-9.20M
2024Q3
742
47.70M
103.68%
-13.09M
2024Q2
766
48.23M
105.00%
-10.57M
2024Q1
786
47.95M
104.43%
-7.71M
2023Q4
812
47.51M
104.50%
-6.33M
2023Q3
817
49.57M
109.64%
-4.16M
2023Q2
820
48.12M
106.76%
-6.53M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
6.82M
14.84%
-119.57K
-1.72%
Jun 30, 2025
The Vanguard Group, Inc.
5.62M
12.23%
+53.75K
+0.97%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.17M
4.72%
+282.10K
+14.97%
Jun 30, 2025
State Street Investment Management (US)
2.09M
4.56%
-73.06K
-3.37%
Jun 30, 2025
Lazard Asset Management, L.L.C.
1.71M
3.72%
+62.73K
+3.81%
Jun 30, 2025
Cadian Capital Management LP
1.66M
3.62%
+1.66M
--
Jun 30, 2025
D. E. Shaw & Co., L.P.
1.42M
3.1%
+25.88K
+1.85%
Jun 30, 2025
Amova Asset Management Co., Ltd.
1.42M
3.1%
+17.68K
+1.26%
Jun 30, 2025
Macquarie Investment Management
1.36M
2.96%
+217.36K
+19.02%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.20M
2.6%
+30.68K
+2.63%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
Global X HealthTech ETF
1.59%
SPDR S&P Health Care Equipment ETF
1.57%
Fidelity Digital Health ETF
1.37%
ROBO Global Healthcare Technology & Innovation ETF
1.12%
Invesco S&P SmallCap Health Care ETF
0.89%
Global X Robotics & Artificial Intelligence ETF
0.55%
Texas Capital Texas Small Cap Equity Index ETF
0.52%
Federated Hermes MDT Small Cap Core ETF
0.48%
Distillate Small/Mid Cash Flow ETF
0.47%
Invesco NASDAQ Future Gen 200 ETF
0.45%
Ver más
Global X HealthTech ETF
Proporción1.59%
SPDR S&P Health Care Equipment ETF
Proporción1.57%
Fidelity Digital Health ETF
Proporción1.37%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.12%
Invesco S&P SmallCap Health Care ETF
Proporción0.89%
Global X Robotics & Artificial Intelligence ETF
Proporción0.55%
Texas Capital Texas Small Cap Equity Index ETF
Proporción0.52%
Federated Hermes MDT Small Cap Core ETF
Proporción0.48%
Distillate Small/Mid Cash Flow ETF
Proporción0.47%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.45%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI